Viking Therapeutics, Inc. Share Price
NASDAQ: VKTX | Mid CapViking Therapeutics, Inc. Stock Performance
Viking Therapeutics, Inc. Share Price Today
As of 30 October 2026, Viking Therapeutics, Inc.'s share price is $26.91. The stock opened at $24.38, compared to its previous close of $25.38. During today's trading session, Viking Therapeutics, Inc.'s share price traded between $24.38 and $27.59, with an average price of $25.98. Over the past 52 weeks, the stock has recorded a high of $43.08 and a low of $23.89. In terms of performance, Viking Therapeutics, Inc.'s share price has declined by 13.56% over the last six months and is down 29.43% on a year-on-year basis.
Viking Therapeutics, Inc. Share Price Chart
Viking Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Viking Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Viking Therapeutics, Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Viking Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $31.95 | $26.85 | -17.71% |
Sep 2026 | $33.08 | $32.63 | -3.76% |
Aug 2026 | $31.43 | $33.91 | +6.75% |
Jul 2026 | $39.44 | $31.76 | -18.62% |
Jun 2026 | $32.22 | $39.02 | +19.29% |
May 2026 | $31.31 | $32.72 | +5.09% |
Apr 2026 | $32.80 | $31.13 | -4.33% |
Mar 2026 | $33.15 | $32.54 | -3.98% |
Feb 2026 | $28.65 | $33.89 | +16.64% |
Jan 2026 | $35.53 | $29.05 | -17.39% |
Dec 2025 | $36.14 | $35.17 | -4.46% |
Nov 2025 | $38.23 | $36.81 | -3.46% |